Baseline medication use is associated with COVID-19 severity in people with rheumatic diseases
(Press-News.org) Due to sample size limitations, previous studies of DMARD use and COVID-19 outcomes have combined several different rheumatic diseases and medications, and investigated a single outcome- for example, the risk of hospitalization. EULAR has given financial support to a global project collecting information on SARS-CoV-2 infection in people with rheumatic diseases. The COVID-19 Global Rheumatology Alliance physician-reported registry launched in March 2020 to collect data on adults with rheumatic disease and confirmed or presumptive COVID-19.
This analysis from Jeffrey Sparks, Zachary Wallace, and colleagues aimed to investigate the associations between baseline use of biologic or targeted synthetic DMARDs with a range of poor COVID-19 outcomes specifically in people with rheumatoid arthritis (RA). The treatments included were abatacept, rituximab, JAK inhibitors (JAKi), interleukin-6 inhibitors (IL-6i), ortumornecrosis factor inhibitors (TNFi). The outcomes were scored on a scale of one to four for COVID-19 severity: 1) no hospitalization, 2) hospitalization without oxygen need, 3) hospitalization with any oxygen need or ventilation, or 4) death. The authors used an analysis to compare each drug class toTNFi.
Of 1,673 people with RA taking b/tsDMARDs when they developed COVID-19, 498 (34.3%) were hospitalized and 112 (6.7%) died. Rituximab users were more likely than TNFi users to have interstitial lung disease(ILD;11.6% versus1.7%) and history of cancer (7.1%versus2.0%); JAKi users were more likely than TNFi users to be obese (17.3%versus9.0%). After propensity score matching, the authors found that rituximab was strongly associated with greater odds of having a worseCOVID-19outcome compared to TNFi. Among rituximab users, 42 (18.8%) died compared to 27 (3.3%) of TNFi users. JAKi use was also associated with greater odds of having a worse COVID-19 severity. People taking abatacept orIL-6ididnot have worseCOVID-19 severity compared to TNFi. Overall, the results were similar in the sensitivity analysis and after excluding cancer or ILD.
Since the abstract was submitted, Sparks adds that the database was refreshed so the numbers have all changed and the sample size is bigger. The main findings are consistent with the initial submission.
Similar results regarding rituximab have been found in the French RMD cohort. Avouac and colleagues reported findings on behalf of a consortium of contributors, includingFAI2R,SFR,SNFMI,SOFREMIP,CRI, and IMIDIATE. Of 1,090peopleincludedwith rheumatic diseases - mainly RA -137 developed severeCOVID-19disease (12.6%). After adjusting for potential confounding factors, severe disease was confirmed to be more frequent in patients receiving rituximab. People who developed severeCOVID-19hadreceived rituximab infusion more recently compared to people with mild or moderate infection.
In this cohort, 89 people cohort died-an overall death rate of 8.2%. Death rate was numerically higher in people receiving rituximab(20.6%) compared to those not(7.4%),and the subgroup of untreated patients with diseases eligible for rituximab therapy (9.9%).However, after adjusting for confounding factors, the risk of death was not significantly increased in people treated with rituximab, although the length of hospital stay was markedly longer in people treated with rituximab compared to both untreated groups.
Results so far from these registriesof people with RA and COVID-19show that baseline use of rituximab or JAKiis associated with worse severity of COVID-19 compared to TNFi use. The elevated odds for poor COVID-19 outcomes in people taking rituximab highlights the urgent need for strategies to limit their risk, such as optimal vaccination timing. The global alliance finding that JAKi are associated with poor COVID-19 outcomes is novel, and needs to be reproduced in other studies.
ELSE PRESS RELEASES FROM THIS DATE:
Climate warming plays a larger role than plant genes in influencing the number and identity of fungal species on oak leaves, especially in autumn. Recently published in the journal New Phytologist, this research by ecologists sheds light on how warming and tree genes affect the dynamics of fungal communities across the season.
"One of our major findings was that elevated temperature decreased the number of fungal species and changed their community composition, especially in the late season" says Maria Faticov, a researcher at the Department of Ecology, Environment and Plant Sciences (DEEP) at Stockholm University.
Plants host thousands of microscopic organisms and leaves are no exception. ...
In this proof-of-concept study, Maja Skov Kragsnaes and colleagues evaluated efficacy and safety of FMT in people with psoriatic arthritis (PsA). PsA is an inflammatory arthritis that causes a person's joints to become stiff and painful. It is often found people with the skin condition psoriasis, and there is also a link between PsA and inflammatory bowel disease or gastrointestinal symptoms.
This double-blind, parallel-group, sham-controlled, superiority trial randomly allocated31adults with active peripheral PsAd espite ongoing treatment with methotrexate to one gastroscopic-guided FMT procedure, or sham transplantation into the duodenum. The transplants (50 g faeces) came from one of four healthy, anonymous stool ...
Massive heavy-lift crane vessels, capable of hauling thousands of tons, navigate the rough waves and strong winds offshore to construct wind turbines and oil fields in the ocean. An international team of researchers has developed a new modeling system to help improve the control, and ultimately the safety, of such vessels. They published their approach in the April issue in IEEE/CAA Journal of Automatica Sinica.
"Dynamic positioning allows the ship to stay fixed in a certain location, by acting on the thruster," said paper author Simone Baldi, professor in the School of Mathematics and School of Cyber Science and Engineering, Southeast University in China, and guest with the Delft Center for System and Control, Delft University of Technology in the Netherlands.
This positioning operation ...
Sweet sorghum can be used to produce biogas, biofuels, and novel polymers. In addition, it can help replace phosphate fertilizers. A new sweet sorghum variety developed at Karlsruhe Institute of Technology (KIT) accumulates particularly high amounts of sugar and thrives under local conditions. As the scientists reported in the Industrial Crops & Products journal, sugar transport and sugar accumulation are related to the structure of the plants' vessels. This was the result of a comparison between sweet and grain sorghums. (DOI: 10.1016/j.indcrop.2021.113550)
As the world's population grows, the demand for food, raw materials, and energy is also on the rise. This increases the burden on the environment and the climate. One strategy to reduce greenhouse gas emissions is to grow so-called ...
Scientists have developed a new technique that could revolutionise medical imaging procedures using light.
A team of physicists, led by Dr David Phillips from the University of Exeter, have pioneered a new way in which to control light that has been scrambled by passage through a single hair-thin strand of optical fibre. These ultra-thin fibres hold much promise for the next generation of medical endoscopes - enabling high-resolution imaging deep inside the body at the tip of a needle.
Conventional endoscopes are millimetres wide and have limited resolution - so cannot be used to inspect individual cells. Single optical fibres are approximately 10x narrower and can enable much higher-resolution imaging - enough to examine the features of individual ...
Various automobile companies are preparing to shift from internal combustion (IC) engine vehicles to electric vehicles (EVs). However, due to higher cost, EVs are not as easily accessible to consumers; hence, several governments are subsidizing EVs to promote sales. For EV costs to compete with those of IC engine vehicles, their batteries, which account for about 30% of their cost, must be more economical than that of IC-based vehicles.
The Korea Institute of Science and Technology (KIST) has announced that Dr. Sang-Ok Kim's team at the Center for Energy Storage Research had developed a novel, high-performance, economical anode material for use in sodium-ion secondary batteries, which are ...
New classes of drugs are biologic disease-modifying anti-rheumatic drugs (bDMARDs) and Januskinase inhibitors (JAKi). At the 2021 EULAR congress, Strangfeld and colleagues shared new data assessing the effects of these medications on the risk of serious infections in elderly people with RA. RA is an inflammatory autoimmune disease that causes pain, swelling, and stiffness in the joints, but it also affects other organ systems through underlying systemic inflammation, causing for example cardiovascular diseases or fatigue.
RABBIT is a prospective, observational cohort study in Germany. ...
The loss of a loved one can be a defining moment, even in the animal world. In chimpanzees, for example, individuals whose mothers die when they are young are smaller than their counterparts, reproduce less and are also more likely to die at a young age. But why? To find out, an international research team* led by a CNRS researcher** studied the short- and long-term effects of maternal loss on the stress levels of orphaned chimpanzees over a 19-year period. By comparing the levels of a stress hormone marker, cortisol, between young and adult orphans and non-orphans, the scientists found that young ...
The body is well protected against invading pathogens by barriers such as the skin. But if you injure yourself and break your skin, pathogens can easily enter your body through the wound and cause severe infections. If this occurs, the innate immune system takes over the first rapid defense with an effective arsenal of cellular weapons infiltrating the wounded tissue in large numbers. As one of the first cell types on the spot, neutrophil granulocytes are recruited within few hours from the bloodstream to the infection site to eliminate potential microbial invaders.
Swarming against infections
"Neutrophils are very efficient in hunting and ...
Singapore, 18 Jun 2021 - Scientists at Duke-NUS Medical School and National Heart Centre Singapore (NHCS), in collaboration with colleagues in Singapore and the UK, have shown that the human form of the signalling protein interleukin 11 (IL-11) has a damaging effect on human liver cells--overturning a prior hypothesis that it could help livers damaged by paracetamol poisoning. The finding, published last week in Science Translational Medicine, suggests that blocking IL-11 signalling could have a restorative effect.
Paracetamol, also called acetaminophen, is a widely available over-the-counter painkiller, and an overdose can lead to serious liver damage and even death. It is the most common pharmaceutical ...
LAST 30 PRESS RELEASES:
[Press-News.org] Baseline medication use is associated with COVID-19 severity in people with rheumatic diseases